Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dementia
Researchers from University of Buenos Aires publish new studies and findings in the area of dementia
November 19th, 2007
A report, 'Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study,' is newly published data in Journal of Pineal Research. According to recent research published in the Journal of Pineal Research, "Mild cognitive impairment (MCI) is an etiologically heterogeneous syndrome characterized by cognitive impairment preceding dementia. Approximately 12% of MCI patients convert to Alzheimer's disease (AD) or other dementia disorders every year." "In the present report we retrospectively examined the initial and final neuropsychological assessment of 50 MCI outpatients, 25 of whom had received daily 3-9 mg of a fast-release...
Source: Pain & Central Nervous System Week (2007-11-19)
|
